Chan Mitchell
SEC CIK 1789335 · EDGAR
BoughtSold
Most active insiders at RGNX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ciongoli Gregory Austin | Dir | $949.4K | — |
| 2 | PAKOLA STEVE | Chief Medical Off | — | $940.0K |
| 3 | Simpson Curran | CEO, Dir | — | $339.1K |
| 4 | Malzahn Craig | CTO | — | — |
| 5 | Bennett Jean | Dir | — | — |
| 6 | Chan Mitchell | CFO | — | — |
| 7 | Zachary Jennifer | Dir | — | — |
| 8 | Glucksmann Alexandra | Dir | — | — |
| 9 | Fox Allan M. | Dir | — | — |
| 10 | Mills Kenneth T. | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 17:29 | 2026-09-01 | RGNX | REGENXBIO Inc. | Chan Mitchell | CFO | F - Tax | $9.32 | -4,902 | 122.8K | -4% | -$45.7K | |
| T | 2026-05-07 16:15 | 2026-05-06 | AVTX | Avalo Therapeutics, Inc. | Chan Mitchell | Dir | S - Sale | $22.88 | -3,167 | 3,166 | -50% | -$72.5K |
| D | 2026-03-31 | 2026-03-28 | AVTX | Avalo Therapeutics, Inc. | Chan Mitchell | Dir | M - OptEx | — | +3,166 | 6,333 | +100% | — |
| D | 2026-01-08 | 2026-01-06 | RGNX | REGENXBIO Inc. | Chan Mitchell | CFO | A - Grant | $0.00 | +73.7K | 127.7K | +137% | $0 |
| 2025-09-03 | 2025-09-01 | RGNX | REGENXBIO Inc. | Chan Mitchell | CFO | F - Tax | $8.93 | -4,901 | 54.0K | -8% | -$43.8K | |
| D | 2025-04-01 | 2025-03-28 | AVTX | Avalo Therapeutics, Inc. | Chan Mitchell | Dir | M - OptEx | — | +3,167 | 3,167 | New | — |
| D | 2024-09-18 | 2024-09-16 | RGNX | REGENXBIO Inc. | Chan Mitchell | CFO | A - Grant | $0.00 | +58.9K | 58.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations